Related references
Note: Only part of the references are listed.Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
Antonio Omuro et al.
NEURO-ONCOLOGY (2023)
RBBP4 regulates the expression of the Mre11-Rad50-NBS1 (MRN) complex and promotes DNA double-strand break repair to mediate glioblastoma chemoradiotherapy resistance
Junjie Li et al.
CANCER LETTERS (2023)
Ultrasound-excited temozolomide sonosensitization induces necroptosis in glioblastoma
Fanchen Wang et al.
CANCER LETTERS (2023)
EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition
Fan Chen et al.
CANCER LETTERS (2022)
SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC
Xiaofeng Li et al.
CANCER LETTERS (2022)
Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing
Ana Hernandez Martinez et al.
CANCER LETTERS (2022)
NEDD4 degrades TUSC2 to promote glioblastoma progression
Tadas K. Rimkus et al.
CANCER LETTERS (2022)
Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics
Shuai Ma et al.
CANCER LETTERS (2022)
HOXA5 is amplified in glioblastoma stem cells and promotes tumor progression by transcriptionally activating PTPRZ1
Zhi-Cheng He et al.
CANCER LETTERS (2022)
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo
Yinan Wang et al.
CANCER LETTERS (2022)
Unconventional tonicity-regulated nuclear trafficking of NFAT5 mediated by KPNB1, XPOT and RUVBL2
Chris Y. Cheung et al.
JOURNAL OF CELL SCIENCE (2022)
GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling
Tao Chen et al.
CANCER LETTERS (2022)
Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma
Angana Biswas et al.
CANCER LETTERS (2022)
Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective
Chen Wang et al.
CANCER LETTERS (2022)
EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling
Yutian Wei et al.
NEURO-ONCOLOGY (2021)
Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity
Yi Liu et al.
NEURO-ONCOLOGY (2021)
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
Yiqi Xu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Repair of O6-carboxymethylguanine adducts by O6-methylguanine-DNA methyltransferase in human colon epithelial cells
Tina Kostka et al.
CARCINOGENESIS (2021)
PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma
Shaofang Wu et al.
NEURO-ONCOLOGY (2021)
Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
Xiangqi Meng et al.
NATURE COMMUNICATIONS (2020)
The evolving role of TonEBP as an immunometabolic stress protein
Soo Youn Choi et al.
NATURE REVIEWS NEPHROLOGY (2020)
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Barbara Oldrini et al.
NATURE COMMUNICATIONS (2020)
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Yi Bao et al.
NATURE COMMUNICATIONS (2020)
PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma
Zuoxin Zhang et al.
CANCER LETTERS (2019)
SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis
Guihua Wang et al.
NATURE CELL BIOLOGY (2019)
Lysine methylation of transcription factors in cancer
Dong Han et al.
CELL DEATH & DISEASE (2019)
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
Raghupathy Vengoji et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
TRAF6 mediates human DNA2 polyubiquitination and nuclear localization to maintain nuclear genome integrity
Yuan Meng et al.
NUCLEIC ACIDS RESEARCH (2019)
Genome-Wide CRISPR-Cas9 Screening Identifies NF-κB/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma
Kai Huang et al.
ADVANCED SCIENCE (2019)
Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
Zeinab Sharifi et al.
CLINICAL CANCER RESEARCH (2019)
CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5
Shuai Zhang et al.
NEURO-ONCOLOGY (2019)
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Jun Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1
Yongsheng Jiang et al.
CELL DEATH & DISEASE (2019)
Role of NFAT5 in the Immune System and Pathogenesis of Autoimmune Diseases
Naeun Lee et al.
FRONTIERS IN IMMUNOLOGY (2019)
SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis
Lan Fang et al.
CANCER CELL (2018)
EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation
Jong-Ho Lee et al.
MOLECULAR CELL (2018)
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
Zhenyi An et al.
ONCOGENE (2018)
TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions
Yu Wang et al.
CANCER LETTERS (2018)
Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ER alpha-GREB1 Transcriptional Axis
Yanming Wu et al.
CANCER RESEARCH (2018)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis
Xueran Chen et al.
JOURNAL OF PINEAL RESEARCH (2016)
TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression
Xian Zhang et al.
MOLECULAR CELL (2016)
Lysine methylation represses p53 activity in teratocarcinoma cancer cells
Jiajun Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Methylation-dependent regulation of HIF-1 alpha stability restricts retinal and tumour angiogenesis
Yunho Kim et al.
NATURE COMMUNICATIONS (2016)
The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin
Merry Gunawan et al.
NATURE IMMUNOLOGY (2015)
Glioblastoma multiforme: Pathogenesis and treatment
Constantinos Alifieris et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Critical roles of non-histone protein lysine methylation in human tumorigenesis
Ryuji Hamamoto et al.
NATURE REVIEWS CANCER (2015)
The functional diversity of protein lysine methylation
Sylvain Lanouette et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma
Hana Janouskova et al.
CANCER RESEARCH (2012)
Oncogenic EGFR Signaling Activates an mTORC2-NF-κB Pathway That Promotes Chemotherapy Resistance
Kazuhiro Tanaka et al.
CANCER DISCOVERY (2011)
Lysine Methylation Regulates E2F1-Induced Cell Death
Haroula Kontaki et al.
MOLECULAR CELL (2010)
Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma
Carmit Levy et al.
MOLECULAR CELL (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter
Marta M. Alonso et al.
CANCER RESEARCH (2007)
The emerging shape of the ESCRT machinery
Roger L. Williams et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Akt-mediated phsophorylationof EZH2 suppresses methylation of lysine 27 in histone H3
TL Cha et al.
SCIENCE (2005)
The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death
RN Trivedi et al.
CANCER RESEARCH (2005)
Role of protein methylation in regulation of transcription
DY Lee et al.
ENDOCRINE REVIEWS (2005)
Regulation of p53 activity through lysine methylation
S Chuikov et al.
NATURE (2004)
The Polycomb EA2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation
G Caretti et al.
GENES & DEVELOPMENT (2004)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The role of NFAT transcription factors in integrin-mediated carcinoma invasion
S Jauliac et al.
NATURE CELL BIOLOGY (2002)
Share Paper
